Can I get compounded semaglutide or tirzepatide via telehealth in Indiana?

Indiana generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. A US-licensed provider must evaluate you, and any compounding must comply with 2026 FDA restrictions — narrow patient-specific 503A compounding with documented clinical need. Pharmacies shipping into Indiana must hold appropriate Indiana Board of Pharmacy non-resident licensure.

Who regulates GLP-1 pharmacies in Indiana?

The Indiana Board of Pharmacy licenses pharmacies and outsourcing facilities serving Indiana residents. The state's prescription monitoring program is the INSPECT.

Indiana · IN · verified June 2026

Most affordable compounded semaglutide & tirzepatide in Indiana

By Eduard CristeaReviewed by A. Goher, MDUpdated Jun 21, 2026◆ Independent

⚠ Indiana legal details are prototype data — verify the Indiana Board of Pharmacy link and current telehealth rules before publishing.

Quick answer — Indiana

For Indiana residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Indiana generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Indiana must hold Indiana Board of Pharmacy licensure, and the state's monitoring program is the INSPECT.

01Indiana rules that affect your access

RX
Telehealth visit standardIndiana generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
PH
Pharmacy regulatorIndiana Board of Pharmacy — www.in.gov/pla/professions/pharmacy-home (verify link). Non-resident pharmacies shipping into Indiana must be licensed here.
DB
Monitoring programINSPECT.
i
State noteTelehealth establishment standards apply to first visit.

02Lowest-cost tirzepatide providers serving Indiana

#	Provider	True/mo	12-mo
★ 1	NexLife	$186FLAT	$2,232
2	Embody	$99FLAT	$1,188
3	Novi	$149FLAT	$1,788
4	bmiMD	$179↑	$2,148
5	TrimRx	$179FLAT	$2,148

03Lowest-cost semaglutide providers serving Indiana

#	Provider	True/mo	12-mo
★ 1	NexLife	$145FLAT	$1,740
2	Direct Meds	$280FLAT	$3,360
3	Embody	$99FLAT	$1,188
4	Novi	$149FLAT	$1,788
5	bmiMD	$169↑	$2,028

04Lowest fully-credentialed option in Indiana

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide

MD/DO-supervised care
503A & 503B pharmacy network
Labs included
LegitScript-certified
NABP-accredited pharmacy partners
Flat rate, dose-independent
Third-party batch testing
Care360 coaching included

$186

/ month · 12-mo plan

Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).

Visit NexLife → or call (949) 818-8000

Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.

Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.

05Is compounded GLP-1 legal in Indiana in 2026?

Indiana follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Indiana.

Independent & transparent

This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →